Jump Financial’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.41M Buy
675,044
+169,592
+34% +$1.6M 0.06% 357
2026
Q1
$4.11M Buy
505,452
+83,009
+20% +$713K 0.05% 415
2025
Q4
$4.39M Buy
422,443
+389,649
+1,188% +$4.09M 0.05% 399
2025
Q3
$290K Sell
32,794
-169,536
-84% -$1.21M ﹤0.01% 1507
2025
Q2
$1.17M Buy
202,330
+9,619
+5% +$58.9K 0.01% 912
2025
Q1
$1.27M Sell
192,711
-47,222
-20% -$368K 0.02% 741
2024
Q4
$2.09M Buy
239,933
+214,993
+862% +$3.09M 0.04% 493
2024
Q3
$487K Sell
24,940
-13,131
-34% -$266K 0.01% 1118
2024
Q2
$784K Sell
38,071
-7,522
-16% -$155K 0.02% 932
2024
Q1
$972K Buy
+45,593
New +$886K 0.03% 816
2023
Q4
Sell
-49,614
Closed -$452K 2014
2023
Q3
$452K Buy
+49,614
New +$504K 0.02% 1077
2023
Q2
Sell
-11,939
Closed -$146K 1991
2023
Q1
$146K Buy
+11,939
New +$149K 0.01% 1377
2022
Q4
Sell
-51,241
Closed -$700K 1829
2022
Q3
$700K Buy
+51,241
New +$790K 0.03% 756
2021
Q3
Sell
-10,700
Closed -$223K 1307
2021
Q2
$223K Buy
+10,700
New +$266K 0.02% 804
2021
Q1
Sell
-7,600
Closed -$248K 1121
2020
Q4
$248K Buy
+7,600
New +$267K 0.04% 679

Other funds holding KURA

Jump Financial's KURA Position: Q2 2026 in Review

Jump Financial increased its Kura Oncology (KURA) stake by 34% in Q2 2026, buying an estimated $1.6M and bringing the position to 675,044 shares worth $7.41M. The position accounts for 0.06% of the portfolio, ranked #357.

Jump Financial first reported a position in KURA in Q4 2020 and has held it in 15 quarters since. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Jump Financial held 675,044 shares of Kura Oncology worth $7.41M as of Q2 2026.
  • Jump Financial bought 169,592 Kura Oncology shares in Q2 2026, an estimated $1.6M.
  • Kura Oncology made up 0.06% of Jump Financial's portfolio in Q2 2026, its #357 holding.
  • Jump Financial first reported a position in Kura Oncology in Q4 2020 and has held it in 15 quarters since.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.